Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global DNA Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2031
Global DNA Sequencing Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-10
Pages: 139 Pages
Report ld: 4923836
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
DNA Sequencing Market Size(US$)
CAGR 2025-2031
16.4%
Market Size,2031
USD 69,863
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 28,132 million
Market Forecast in 2031(Value)
US$ 69,863 million
CAGR
16.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global DNA Sequencing market is projected to grow from US$ 23728 million in 2024 to US$ 69863 million by 2031, at a CAGR of 16.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
DNA Sequencing is a core technology used to determine the order of nucleotides (A, T, C, G) in a DNA molecule. By comprehensively analyzing genomes, this technology reveals individual genetic variations and disease-related mutations. The dominant platforms include Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS), which offer high throughput, precision, and scalability. DNA sequencing is widely applied in disease diagnosis, cancer precision medicine, reproductive health, microbiology, agricultural breeding, and forensic science. It has become a foundational driver for the advancement of precision medicine, biopharmaceutical R&D, and the bioinformatics industry, profoundly transforming the research paradigm in life sciences.
With growing global demand for precision medicine, biodiversity research, and personalized healthcare. Key drivers include increased government funding in public health and disease prevention, dramatic reductions in sequencing costs, enhanced interpretation efficiency enabled by AI and cloud computing, and the rapid adoption of high-growth applications such as liquid biopsy and non-invasive prenatal testing (NIPT). Regulatory environments are also maturing, facilitating faster commercialization.
Despite continuous technological advancements, the DNA sequencing industry faces notable challenges, including raw material price volatility, data security compliance, IP barriers, and inconsistencies in clinical interpretation. High-end sequencing platforms heavily depend on stable supply chains, with critical components such as chips and enzymes monopolized by a few suppliers, making them vulnerable to geopolitical disruptions. In developed regions, stricter legislation on genetic privacy introduces compliance burdens for global service providers. Emerging markets like China also face constraints in terms of reimbursement systems and clinical adoption pathways for advanced testing services.
In high-value application areas like cancer screening, rare disease diagnostics, birth defect prevention, and reproductive health, downstream demand is shifting toward customized solutions tailored to specific diseases. Demand for whole-genome and single-cell sequencing is also rising rapidly among pharmaceutical companies and CROs, driving convergence with AI-enabled diagnostics and CDx platforms. National regulations on human genetic resource management are propelling local database initiatives and ecosystem upgrades. In the foreseeable future, sequencing data will become the foundation of medical decision-making and drug discovery, fueling new business models such as Data-as-a-Service (DaaS) and genomic cloud platforms.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global DNA Sequencing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Illumina
- Thermo Fisher Scientific
- Eurofins Scientific
- BGI
- Natera
- Berry Genomics
- Roche
- Novo Gene
- MGI-Tech
- LabCorp
- Pacific Biosciences
- Azenta Life Sciences
- Oxford Nanopore
- Macrogen
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- First Generation DNA Sequencing
- Second Generation DNA Sequencing
- Third Generation DNA Sequencing
Segment by Application
- Academic Research
- Clinical Research
- Hospitals and Clinics
- Pharmaceuticals and Biotechnology
- Other
CHAPTER OUTLINE
Chapter 1: Defines the DNA Sequencing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to DNA Sequencing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global DNA Sequencing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 First Generation DNA Sequencing
1.2.3 Second Generation DNA Sequencing
1.2.4 Third Generation DNA Sequencing
1.3 Market Segmentation by Application
1.3.1 Global DNA Sequencing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Academic Research
1.3.3 Clinical Research
1.3.4 Hospitals and Clinics
1.3.5 Pharmaceuticals and Biotechnology
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global DNA Sequencing Revenue Estimates and Forecasts 2020-2031
2.2 Global DNA Sequencing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global DNA Sequencing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global DNA Sequencing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 First Generation DNA Sequencing Market Size by Players
3.3.2 Second Generation DNA Sequencing Market Size by Players
3.3.3 Third Generation DNA Sequencing Market Size by Players
3.4 Global DNA Sequencing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global DNA Sequencing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global DNA Sequencing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America DNA Sequencing Market Size by Type (2020-2031)
6.4 North America DNA Sequencing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America DNA Sequencing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe DNA Sequencing Market Size by Type (2020-2031)
7.4 Europe DNA Sequencing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe DNA Sequencing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific DNA Sequencing Market Size by Type (2020-2031)
8.4 Asia-Pacific DNA Sequencing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific DNA Sequencing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America DNA Sequencing Market Size by Type (2020-2031)
9.4 Central and South America DNA Sequencing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America DNA Sequencing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa DNA Sequencing Market Size by Type (2020-2031)
10.4 Middle East and Africa DNA Sequencing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa DNA Sequencing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina DNA Sequencing Product Features and Attributes
11.1.4 Illumina DNA Sequencing Revenue and Gross Margin (2020-2025)
11.1.5 Illumina DNA Sequencing Revenue by Product in 2024
11.1.6 Illumina DNA Sequencing Revenue by Application in 2024
11.1.7 Illumina DNA Sequencing Revenue by Geographic Area in 2024
11.1.8 Illumina DNA Sequencing SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific DNA Sequencing Product Features and Attributes
11.2.4 Thermo Fisher Scientific DNA Sequencing Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific DNA Sequencing Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific DNA Sequencing Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific DNA Sequencing Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific DNA Sequencing SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Corporation Information
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific DNA Sequencing Product Features and Attributes
11.3.4 Eurofins Scientific DNA Sequencing Revenue and Gross Margin (2020-2025)
11.3.5 Eurofins Scientific DNA Sequencing Revenue by Product in 2024
11.3.6 Eurofins Scientific DNA Sequencing Revenue by Application in 2024
11.3.7 Eurofins Scientific DNA Sequencing Revenue by Geographic Area in 2024
11.3.8 Eurofins Scientific DNA Sequencing SWOT Analysis
11.3.9 Eurofins Scientific Recent Developments
11.4 BGI
11.4.1 BGI Corporation Information
11.4.2 BGI Business Overview
11.4.3 BGI DNA Sequencing Product Features and Attributes
11.4.4 BGI DNA Sequencing Revenue and Gross Margin (2020-2025)
11.4.5 BGI DNA Sequencing Revenue by Product in 2024
11.4.6 BGI DNA Sequencing Revenue by Application in 2024
11.4.7 BGI DNA Sequencing Revenue by Geographic Area in 2024
11.4.8 BGI DNA Sequencing SWOT Analysis
11.4.9 BGI Recent Developments
11.5 Natera
11.5.1 Natera Corporation Information
11.5.2 Natera Business Overview
11.5.3 Natera DNA Sequencing Product Features and Attributes
11.5.4 Natera DNA Sequencing Revenue and Gross Margin (2020-2025)
11.5.5 Natera DNA Sequencing Revenue by Product in 2024
11.5.6 Natera DNA Sequencing Revenue by Application in 2024
11.5.7 Natera DNA Sequencing Revenue by Geographic Area in 2024
11.5.8 Natera DNA Sequencing SWOT Analysis
11.5.9 Natera Recent Developments
11.6 Berry Genomics
11.6.1 Berry Genomics Corporation Information
11.6.2 Berry Genomics Business Overview
11.6.3 Berry Genomics DNA Sequencing Product Features and Attributes
11.6.4 Berry Genomics DNA Sequencing Revenue and Gross Margin (2020-2025)
11.6.5 Berry Genomics Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Business Overview
11.7.3 Roche DNA Sequencing Product Features and Attributes
11.7.4 Roche DNA Sequencing Revenue and Gross Margin (2020-2025)
11.7.5 Roche Recent Developments
11.8 Novo Gene
11.8.1 Novo Gene Corporation Information
11.8.2 Novo Gene Business Overview
11.8.3 Novo Gene DNA Sequencing Product Features and Attributes
11.8.4 Novo Gene DNA Sequencing Revenue and Gross Margin (2020-2025)
11.8.5 Novo Gene Recent Developments
11.9 MGI-Tech
11.9.1 MGI-Tech Corporation Information
11.9.2 MGI-Tech Business Overview
11.9.3 MGI-Tech DNA Sequencing Product Features and Attributes
11.9.4 MGI-Tech DNA Sequencing Revenue and Gross Margin (2020-2025)
11.9.5 MGI-Tech Recent Developments
11.10 LabCorp
11.10.1 LabCorp Corporation Information
11.10.2 LabCorp Business Overview
11.10.3 LabCorp DNA Sequencing Product Features and Attributes
11.10.4 LabCorp DNA Sequencing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Pacific Biosciences
11.11.1 Pacific Biosciences Corporation Information
11.11.2 Pacific Biosciences Business Overview
11.11.3 Pacific Biosciences DNA Sequencing Product Features and Attributes
11.11.4 Pacific Biosciences DNA Sequencing Revenue and Gross Margin (2020-2025)
11.11.5 Pacific Biosciences Recent Developments
11.12 Azenta Life Sciences
11.12.1 Azenta Life Sciences Corporation Information
11.12.2 Azenta Life Sciences Business Overview
11.12.3 Azenta Life Sciences DNA Sequencing Product Features and Attributes
11.12.4 Azenta Life Sciences DNA Sequencing Revenue and Gross Margin (2020-2025)
11.12.5 Azenta Life Sciences Recent Developments
11.13 Oxford Nanopore
11.13.1 Oxford Nanopore Corporation Information
11.13.2 Oxford Nanopore Business Overview
11.13.3 Oxford Nanopore DNA Sequencing Product Features and Attributes
11.13.4 Oxford Nanopore DNA Sequencing Revenue and Gross Margin (2020-2025)
11.13.5 Oxford Nanopore Recent Developments
11.14 Macrogen
11.14.1 Macrogen Corporation Information
11.14.2 Macrogen Business Overview
11.14.3 Macrogen DNA Sequencing Product Features and Attributes
11.14.4 Macrogen DNA Sequencing Revenue and Gross Margin (2020-2025)
11.14.5 Macrogen Recent Developments
12 DNA SequencingIndustry Chain Analysis
12.1 DNA Sequencing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 DNA Sequencing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global DNA Sequencing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global DNA Sequencing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global DNA Sequencing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global DNA Sequencing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global DNA Sequencing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global DNA Sequencing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global DNA Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global DNA Sequencing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global DNA Sequencing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Sequencing as of 2024)
Table 11. Global DNA Sequencing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global DNA Sequencing Companies Headquarters
Table 13. Global DNA Sequencing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global DNA Sequencing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global DNA Sequencing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global DNA Sequencing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global DNA Sequencing Revenue by Application (2026-2031) & (US$ Million)
Table 21. DNA Sequencing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America DNA Sequencing Growth Accelerators and Market Barriers
Table 25. North America DNA Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe DNA Sequencing Growth Accelerators and Market Barriers
Table 27. Europe DNA Sequencing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific DNA Sequencing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific DNA Sequencing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America DNA Sequencing Investment Opportunities and Key Challenges
Table 31. Central and South America DNA Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa DNA Sequencing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa DNA Sequencing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Illumina Corporation Information
Table 35. Illumina Description and Major Businesses
Table 36. Illumina Product Features and Attributes
Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Illumina Revenue Proportion by Product in 2024
Table 39. Illumina Revenue Proportion by Application in 2024
Table 40. Illumina Revenue Proportion by Geographic Area in 2024
Table 41. Illumina DNA Sequencing SWOT Analysis
Table 42. Illumina Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Major Businesses
Table 45. Thermo Fisher Scientific Product Features and Attributes
Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific DNA Sequencing SWOT Analysis
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. Eurofins Scientific Corporation Information
Table 53. Eurofins Scientific Description and Major Businesses
Table 54. Eurofins Scientific Product Features and Attributes
Table 55. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Eurofins Scientific Revenue Proportion by Product in 2024
Table 57. Eurofins Scientific Revenue Proportion by Application in 2024
Table 58. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 59. Eurofins Scientific DNA Sequencing SWOT Analysis
Table 60. Eurofins Scientific Recent Developments
Table 61. BGI Corporation Information
Table 62. BGI Description and Major Businesses
Table 63. BGI Product Features and Attributes
Table 64. BGI Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. BGI Revenue Proportion by Product in 2024
Table 66. BGI Revenue Proportion by Application in 2024
Table 67. BGI Revenue Proportion by Geographic Area in 2024
Table 68. BGI DNA Sequencing SWOT Analysis
Table 69. BGI Recent Developments
Table 70. Natera Corporation Information
Table 71. Natera Description and Major Businesses
Table 72. Natera Product Features and Attributes
Table 73. Natera Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Natera Revenue Proportion by Product in 2024
Table 75. Natera Revenue Proportion by Application in 2024
Table 76. Natera Revenue Proportion by Geographic Area in 2024
Table 77. Natera DNA Sequencing SWOT Analysis
Table 78. Natera Recent Developments
Table 79. Berry Genomics Corporation Information
Table 80. Berry Genomics Description and Major Businesses
Table 81. Berry Genomics Product Features and Attributes
Table 82. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Berry Genomics Recent Developments
Table 84. Roche Corporation Information
Table 85. Roche Description and Major Businesses
Table 86. Roche Product Features and Attributes
Table 87. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Roche Recent Developments
Table 89. Novo Gene Corporation Information
Table 90. Novo Gene Description and Major Businesses
Table 91. Novo Gene Product Features and Attributes
Table 92. Novo Gene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Novo Gene Recent Developments
Table 94. MGI-Tech Corporation Information
Table 95. MGI-Tech Description and Major Businesses
Table 96. MGI-Tech Product Features and Attributes
Table 97. MGI-Tech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. MGI-Tech Recent Developments
Table 99. LabCorp Corporation Information
Table 100. LabCorp Description and Major Businesses
Table 101. LabCorp Product Features and Attributes
Table 102. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. LabCorp Recent Developments
Table 104. Pacific Biosciences Corporation Information
Table 105. Pacific Biosciences Description and Major Businesses
Table 106. Pacific Biosciences Product Features and Attributes
Table 107. Pacific Biosciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Pacific Biosciences Recent Developments
Table 109. Azenta Life Sciences Corporation Information
Table 110. Azenta Life Sciences Description and Major Businesses
Table 111. Azenta Life Sciences Product Features and Attributes
Table 112. Azenta Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Azenta Life Sciences Recent Developments
Table 114. Oxford Nanopore Corporation Information
Table 115. Oxford Nanopore Description and Major Businesses
Table 116. Oxford Nanopore Product Features and Attributes
Table 117. Oxford Nanopore Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Oxford Nanopore Recent Developments
Table 119. Macrogen Corporation Information
Table 120. Macrogen Description and Major Businesses
Table 121. Macrogen Product Features and Attributes
Table 122. Macrogen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Macrogen Recent Developments
Table 124. Raw Materials Key Suppliers
Table 125. Distributors List
Table 126. Market Trends and Market Evolution
Table 127. Market Drivers and Opportunities
Table 128. Market Challenges, Risks, and Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. DNA Sequencing Product Picture
Figure 2. Global DNA Sequencing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. First Generation DNA Sequencing Product Picture
Figure 4. Second Generation DNA Sequencing Product Picture
Figure 5. Third Generation DNA Sequencing Product Picture
Figure 6. Global DNA Sequencing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Academic Research
Figure 8. Clinical Research
Figure 9. Hospitals and Clinics
Figure 10. Pharmaceuticals and Biotechnology
Figure 11. Other
Figure 12. DNA Sequencing Report Years Considered
Figure 13. Global DNA Sequencing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 15. Global DNA Sequencing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global DNA Sequencing Revenue Market Share by Region (2020-2031)
Figure 17. Global DNA Sequencing Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. First Generation DNA Sequencing Revenue Market Share by Player in 2024
Figure 20. Second Generation DNA Sequencing Revenue Market Share by Player in 2024
Figure 21. Third Generation DNA Sequencing Revenue Market Share by Player in 2024
Figure 22. Global DNA Sequencing Revenue Market Share by Type (2020-2031)
Figure 23. Global DNA Sequencing Revenue Market Share by Application (2020-2031)
Figure 24. North America DNA Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players DNA Sequencing Revenue (US$ Million) in 2024
Figure 26. North America DNA Sequencing Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America DNA Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 28. US DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 29. Canada DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 31. Europe DNA Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players DNA Sequencing Revenue (US$ Million) in 2024
Figure 33. Europe DNA Sequencing Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe DNA Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 36. France DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 38. Italy DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 39. Russia DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific DNA Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players DNA Sequencing Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific DNA Sequencing Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific DNA Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 45. Japan DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 47. Australia DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 48. India DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore DNA Sequencing Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America DNA Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players DNA Sequencing Revenue (US$ Million) in 2024
Figure 56. Central and South America DNA Sequencing Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America DNA Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil DNA Sequencing Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina DNA Sequencing Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa DNA Sequencing Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players DNA Sequencing Revenue (US$ Million) in 2024
Figure 62. South America DNA Sequencing Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa DNA Sequencing Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries DNA Sequencing Revenue (2020-2025) & (US$ Million)
Figure 65. Israel DNA Sequencing Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt DNA Sequencing Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa DNA Sequencing Revenue (2020-2025) & (US$ Million)
Figure 68. DNA Sequencing Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of DNA Sequencing in 2025?
The global market size of DNA Sequencing in 2025 was 28132 Million USD.
What is the annual compound growth rate of the global DNA Sequencing market size from 2025 to 2031?
Which companies rank high in the global DNA Sequencing market?
Which region is expected to have the highest market share?
What was the global market size of DNA Sequencing in 2031?
Related Reports
Global DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global DNA Sequencing market size was US$ 28130 million in 2025 and is forecast to reach a readjusted size of US$ 80160 million by 2032 with a CAGR of 16.4% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 96
USD 4250.00
(Single User License)
Global DNA Sequencing Market Research Report 2026
The global DNA Sequencing market was valued at US$ 28130 million in 2025 and is anticipated to reach US$ 80160 million by 2032, at a CAGR of 16.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for DNA Sequencing was estimated to be worth US$ 28130 million in 2025 and is projected to reach US$ 80160 million, growing at a CAGR of 16.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 112
USD 3950.00
(Single User License)
DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for DNA Sequencing was estimated to be worth US$ 23728 million in 2024 and is forecast to a readjusted size of US$ 69863 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.
Published Date: 2025-10-21
Pages: 108
USD 3950.00
(Single User License)
Global DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global DNA Sequencing market size was US$ 23728 million in 2024 and is forecast to a readjusted size of US$ 69863 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 94
USD 4250.00
(Single User License)
Global DNA Sequencing Market Research Report 2025
The global market for DNA Sequencing was valued at US$ 23728 million in the year 2024 and is projected to reach a revised size of US$ 69863 million by 2031, growing at a CAGR of 16.4% during the forecast period.
Published Date: 2025-08-12
Pages: 84
USD 2900.00
(Single User License)
Global DNA Sequencing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of DNA Sequencing was estimated to be worth US$ 23110 million and is forecast to reach approximately US$ 83340 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 136
USD 5900.00
(Single User License)
DNA Sequencing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for DNA Sequencing was estimated to be worth US$ 23110 million in 2024 and is forecast to a readjusted size of US$ 83340 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 91
USD 3950.00
(Single User License)
Global DNA Sequencing Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA.
Published Date: 2024-04-17
Pages: 138
USD 5600.00
(Single User License)
Global DNA Sequencing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA.
Published Date: 2024-04-16
Pages: 132
USD 5900.00
(Single User License)
Global DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global DNA Sequencing market size was US$ 28130 million in 2025 and is forecast to reach a readjusted size of US$ 80160 million by 2032 with a CAGR of 16.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 96
USD 4250.00 (Single User License)Global DNA Sequencing Market Research Report 2026
The global DNA Sequencing market was valued at US$ 28130 million in 2025 and is anticipated to reach US$ 80160 million by 2032, at a CAGR of 16.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for DNA Sequencing was estimated to be worth US$ 28130 million in 2025 and is projected to reach US$ 80160 million, growing at a CAGR of 16.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 112
USD 3950.00 (Single User License)DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for DNA Sequencing was estimated to be worth US$ 23728 million in 2024 and is forecast to a readjusted size of US$ 69863 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.
Published: 2025-10-21
Pages: 108
USD 3950.00 (Single User License)Global DNA Sequencing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global DNA Sequencing market size was US$ 23728 million in 2024 and is forecast to a readjusted size of US$ 69863 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 94
USD 4250.00 (Single User License)Global DNA Sequencing Market Research Report 2025
The global market for DNA Sequencing was valued at US$ 23728 million in the year 2024 and is projected to reach a revised size of US$ 69863 million by 2031, growing at a CAGR of 16.4% during the forecast period.
Published: 2025-08-12
Pages: 84
USD 2900.00 (Single User License)Global DNA Sequencing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of DNA Sequencing was estimated to be worth US$ 23110 million and is forecast to reach approximately US$ 83340 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 136
USD 5900.00 (Single User License)DNA Sequencing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for DNA Sequencing was estimated to be worth US$ 23110 million in 2024 and is forecast to a readjusted size of US$ 83340 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 91
USD 3950.00 (Single User License)Global DNA Sequencing Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA.
Published: 2024-04-17
Pages: 138
USD 5600.00 (Single User License)Global DNA Sequencing Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA.
Published: 2024-04-16
Pages: 132
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now